People who suffer from inflammatory and metabolic diseases deserve better help

Current solutions for chronic inflammatory & metabolic disease are ineffective and unsustainable, and generic solutions fail due to lack of personalization. 

Most patients only see their physicians a few times a year. They are usually given the standard advice to eat less and exercise more, and even when they follow that advice, they are usually put on more and more medications as time goes on.

Revero claims to treat the root causes of chronic diseases

Revero has helped thousands of people in our community regain their health with a carnivore based elimination diet. In the future Revero is planning to go fully medical to reverse chronic diseases and provide AI-based nutritional therapy. Revero can identify and eliminate the foods that are causing the health issues for each patient, and get the same amazing results as the elimination diet without being too restrictive.

With Revero’s online platform, the Company is transforming the treatment of chronic diseases by providing AI-based medical nutritional therapy, continuous remote care, and behavioral support.

What the treatment entails

Why now? Why Revero?

Reversing chronic diseases in Revero's data-driven virtual-first clinic

Enter demographics + health conditions data

• Patient is onboarded with a doctor, adds demographics, lifestyle, and health data
• Revero's AI algorithms personalize the nutritional therapy for patient's unique characteristics 

AI-based personalized treatment + biomarkers

• Revero's medical nutritional therapy removes the foods that are contributing to disease and includes optimal foods
• Revero also adjusts the treatment based on the patient’s biomarkers and symptoms

De-prescription of meds + biomarkers feedback

• As patients improve, Revero's physicians de-prescribe the medications and provide on-demand support
• Patients can track their historical progress and get coaching and community support

Disclaimer: Revero is awaiting verification and medical trials to confirm its technology and treatment goals. It is currently not practicing medicine and makes no present claims about treating diseases. The information on this page reflects the future plans of the Company. Please contact your healthcare provider for medical advice.

$400K+ ARR with 56% compound monthly growth

Revero launched two years ago, and organically grew to 2.8K+ paying subscribers and $400K+ in ARR. Revero has had 6K+ coaching sessions, and their podcast is ranked top 40 on Apple charts.

Subscription metrics

12K+ people have reported health improvements

The following is a summary of results from a health survey of 12,000 people reporting improvement in their health conditions as a result of the carnivore-based elimination diet.

Success stories

Reimbursement by health plans and employers

Go-to-market strategy

Our main go-to-market strategy is selling directly to self-insured employers to save money on their medical claims budget, as well as reimbursement from health insurance companies to save more on their cost of medical claims. 

Subscription structure

$152B serviceable
obtainable market

According to Revero's research, the serviceable addressable market is $862B globally and $608B for the US. Assuming Revero captures 25%, Revero will have a serviceable obtainable market of $152B in the US.

US market

• Approximately 8M companies in the US
• This represents about 133M employees
• 2.3 billion people worldwide have multiple medical conditions

Revero is more effective and treats more conditions than competitors

Revero treats the underlying health issues
rather than just the symptoms

One of Revero's most comparable competitors, Livongo, recently went public with an $18.5B acquisition. This shows a high demand for the product in the broader market. Revero is far superior to Omada and Virta (valued $2B) in both effectiveness and the range of health disorders it can treat—including diabetes, inflammatory, autoimmune conditions, and more. 

Revero is a new treatment paradigm. Revero treats the root pathways of diseases rather than just the symptoms.

A look into Revero's future milestones and strategies

What's next for Revero?

Estimated financial projections

Mahsa Rostami

Co-founder & CEO

• AI engineer, expert in healthcare AI
• MS in Engineering, Data Science focus from Texas A&M
• Developed deep learning AI solutions for CMS.gov that improved health services for millions of people

Shawn Baker MD

Co-founder & Chief Medical Officer

• Orthopedic surgeon
• Expert in medical nutritional therapy
• Best-selling author
• International speaker
• World champion athlete

In addition to the carried interest Republic Deal Room Advisor LLC is entitled to for the syndicated investments it organizes, certain principals of Republic Deal Room Advisor LLC may have a personal interests in these investments, as disclosed below. When making an investment decision please review any applicable disclosures as they represent pre-existing financial interests held by those principals of Republic Deal Room Advisor LLC.

We do not represent that the information contained herein is accurate or complete, and it should not be relied upon as such. Opinions expressed herein are subject to change without notice. Certain information contained herein (including any forward-looking statements and economic and market information) has been obtained from and/or prepared by the Company or other third-party sources and in certain cases has not been updated through the date hereof. While such sources are believed to be reliable, Republic Deal Room Advisor LLC does not assume any responsibility for the accuracy or completeness of such information. Republic Deal Room Advisor LLC does not undertake any obligation to update the information contained herein as of any future date.